What's new? Log in Free sign up

Bristol-Myers Squibb (BMY) Environmental, Social & Governance (ESG) Data

Company Profile

Search within these filings

View filings

Exhibits within filings

Filing insights

Export filings list

Export a CSV file of filings or unique filing companies (up to first 5,000 results).

Download list of filings Download list of companies

Employees

Data from SEC filings

Employee count

CEO pay ratio

CEO Salary

Median Employee Salary

ESG framework mentions

In last year of SEC filings

Sustainability Accounting Standards Board (SASB)

Definitive proxy

Global Reporting Initiative (GRI)

Definitive proxy

Task Force on Climate-related Financial Disclosures (TCFD)

Definitive proxy

UN Sustainable Development Goals (SDGs)

Definitive proxy

ESG term mentions

In last year of SEC filings

Air Carbon Neutral Clean Climate Climate Change Conservation Ecosystem Emission Environment Environmental Environmental Protection GHG GHG Emissions Intensity Landfill Life Cycle Lifecycle Materials Natural Resources Nature Offset Package Packaging Pandemic Planet Pollutant Pollution Raw Materials Renewable Resiliency Scarcity Science Based Targets Scope 1 Scope 2 Scope 3 Soil Waste Water Zero Emission Access Access and affordability Affordability African American Asian Attrition Benefits Black Charitable Citizenship Community Culture Customer Cyber Cybersecurity Data Privacy Data Security Death Demographics Disability Diversity Diversity and Inclusion Diversity Officer Drug Pricing EEO-1 Employee Employee Engagement Engagement Ethnic Ethnicity Gender General Data Protection Regulation Health and Safety Health Care Healthcare Hire Hiring Hispanic Human Capital Human Resources Incident Inequality Injuries Injury LGBTQ Opioid Parental Leave Pay for Performance Perquisites Privacy Product Quality Product Safety Pulse Survey Racism Racist Recall Recruit Recruitment Reimbursement Resource Group Retention Retirement Safety Satisfaction Skill Skills Social Society Stakeholder Supplier Supplier Diversity Supply Chain Talent Training Union Volunteer Women Workers Workforce Anti-corruption Antitrust Assessment Assurance Attorney General Attorneys General Audit Board Evaluation Board Oversight Board Refreshment Bonus Bribery Chronic Class Action Lawsuit Classified Clawback Commitment Committee Evaluation Conflict of Interest Controversy Corporate Governance Corruption Department of ESG Ethics Executive Compensation Expert Fraud Goals Governance Hedging Incentive Incentivize Independence Independent Independent Chair Independent Lead Director Inequality Innovate Innovation Innovative Investigation Lawsuit Lead Independent Director Leadership Litigation Long-term Majority Mission Other Public Company Boards Oversee Oversight Perquisite Plaintiff Pledging Procurement Proxy Access Purpose Quality Standard R&D Recoup Reputation Reputational Reputational Risk Research and Development Responsibility Responsible Shareholder Engagement Shareholder Proposals Special Meeting Stewardship Strategy Sustainability Sustainable Targets Tax Tenure Transparency Transparent Voting Rights

Shareholder alignment

Proxy contests and exempt solicitations in last 3 years

BMY Bristol-Myers Squibb Co.

Letter to shareholders

BMY Bristol-Myers Squibb Co.

Letter to shareholders

BMY Bristol-Myers Squibb Co.

Letter to shareholders

Vote support at last AGM

(a)	The Annual Meeting of the Company was held on May 3, 2022.

(b)	Shareholders voted on the matters set forth below.

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.